BioAtla, Inc. (BCAB) stock

BCABOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 4/30

$1.31−0.05 (-3.68%)

Close on Oct 19, 2026Market cap $2.18MP/E –Yield –

BioAtla total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioAtla has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?